Blossomhill Therapeutics, Inc. · NASDAQ:BLSM
Keyes Jason A bought 700 Blossomhill Therapeutics, Inc. shares (Form 4)
Traded Aug 10, 2026 · Filed Aug 10, 2026
On Aug 10, 2026, Keyes Jason A (Chief Financial Officer) bought 700 Blossomhill Therapeutics, Inc. shares at US$16.00 for US$11,200, leaving 700 shares. Filed Aug 10, 2026 (Form 4).
- Bought
- 700 shares
- Price
- US$16.00
- Value
- US$11,200
- Holding after
- 700 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Common Stock | Buy | 700 | US$16.00 | 700 | Direct |
Source
Related
- Blossomhill Therapeutics, Inc.
- Keyes Jason A
- Blossomhill Therapeutics, Inc. shareholders
- Schedule 13D · Orbimed Advisors LLC · Aug 18, 2026
- Schedule 13G · Vivo Innovation Fund II Holdings, L.P. · Aug 17, 2026
- Schedule 13G · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13D · Chen Bihua · Aug 13, 2026
- Form 4 · Gordon Carl L · Aug 12, 2026